News
Panaxia sells Israeli cannabis pharmacy to focus on exports
May 6, 2021
May 3 2021 | Globes Panaxia Israel is selling its pharmacy, one of Israel’s largest for cannabis products, to IMC for NIS 20 million. Six months
Panaxia Israel announces estimated record revenues of at least 19 million in Q1 2021
April 18, 2021
April 12, 2021 | Market Watch LOD, Israel, April 12, 2021 /PRNewswire/ — The Israeli subsidiary of Panaxia Global, Panaxia Labs Israel Ltd. (“Panaxia Israel”) (TASE: PNAX), Israel’s largest manufacturer of
How did one company take charge of Israel’s medical cannabis market?
April 18, 2021
Since November of 2020, any Israeli company wishing to export cannabis has first been required to work with Panaxia.By IDAN ZONSHINE April 15, 2021 | JPost As
Could cannabis help cure Israel’s corona economic crisis?
April 6, 2021
Panaxia Israel Laboratories expands into EU marketplace despite challenges posed by year of COVID-19.By MAAYAN JAFFE-HOFFMAN April 5, 2021 | JPost A first shipment of Israeli medical cannabis products